TNF-α inhibition with infliximab and FR167653 decreased urinary albumin excretion, suggesting the role of TNF-α in the pathogenesis of diabetic nephropathy, with TNF-α inhibition is a potential therapeutic strategy. The gene discussed is ALB; the disease is diabetic kidney disease.